Tomas Odergren
Chief Tech/Sci/R&D Officer at BIOARCTIC AB
Net worth: 101 267 $ as of 2024-04-29
Network origin in Tomas Odergren first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
| Public Company | Financial Conglomerates | 12 | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tomas Odergren via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chairman Director of Finance/CFO Chief Executive Officer | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| INDEX PHARMACEUTICALS HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Stockholm | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Director/Board Member Founder | |
| Royal Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| AROCELL AB | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apotek Produktion & Laboratorier AB
 Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Extenda AB
 Extenda AB Information Technology ServicesTechnology Services Extenda AB develops point-of-sale technology (POS) solutions. Its product suite include transaction engine, selfscan, mobile POS, and self checkout. The firm also offers support, service and maintenance, and catalogue services. The company was founded by Peter Carlman in 1982 and is headquartered in Stockholm, Sweden. | Information Technology Services | Director of Finance/CFO | |
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact Public Communications Contact | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| HANZA AB | Steel | Director/Board Member Chairman | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Disruptive Materials AB
 Disruptive Materials AB Chemicals: Major DiversifiedProcess Industries Disruptive Materials AB manufactures mesoporous magnesium carbonate. It focuses on commercializing the material Upsalite that can be used in applications such as desiccant for humidity control, pharmaceutics, adsorbent for waste handling, thermal and acoustic insulation, cosmetics, adsorbent in ink jet paper,and bio material applications. The company was founded by Johan A. V. Gómez de la Torre, Maria Strømme, Lars-Erik Mattias Karls, and Sara Kristina Frykstrand Ångström in December 2011 and is headquartered in Uppsala, Sweden. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
MD International AB
 MD International AB Medical/Nursing ServicesHealth Services MD International AB provides digital healthcare services. It operates an online platform for patients with disabilities and sickness. The company was founded by Lars Magnus Nyhlen in 2013 and is headquartered in Malmö, Sweden. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Chief Executive Officer Director/Board Member | |
| SP Process Development AB | Director/Board Member Director/Board Member | ||
| Förvaltningsaktiebolaget Kanalen AB | Director/Board Member | ||
Konditori Solsidan AB
 Konditori Solsidan AB Food RetailRetail Trade Konditori Solsidan AB is a Swedish company that retails bakery products. The private company is based in Stockholm, Sweden. | Food Retail | Chairman | |
Spinemedical Sverige AB
 Spinemedical Sverige AB Miscellaneous Commercial ServicesCommercial Services Spinemedical Sverige AB provides research and development services on surgical treatment. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Spinemedical AB
 Spinemedical AB Medical/Nursing ServicesHealth Services Spinemedical AB provides surgical treatment and rehabilitation services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Lpb Sweden AB
 Lpb Sweden AB Real Estate DevelopmentFinance Lpb Sweden AB provides movable and immovable property services. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Lpb Sweden Holding AB
 Lpb Sweden Holding AB Real Estate DevelopmentFinance Lpb Sweden Holding AB is a Swedish company that owns and manages movable and immovable properties. The private company is based in Stockholm, Sweden. | Real Estate Development | Director/Board Member Founder Director/Board Member | |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director/Board Member Director/Board Member Director of Finance/CFO | |
Hanza Operations AB
 Hanza Operations AB Electronic Production EquipmentElectronic Technology Hanza AB engages in the manufacture and distribution of electronic equipment. It offers manufacturing services that include mechanics, electronics, cables and boxes. The company was founded by Erik Ivar Bertil Stenfor on January 28, 2008 and is headquartered in Stocksund, Sweden. | Electronic Production Equipment | Director/Board Member Chairman | |
| BACTIGUARD HOLDING AB | Medical Specialties | Chief Executive Officer Chief Executive Officer |
Statistics
International
| Sweden | 46 |
| Denmark | 5 |
| Italy | 2 |
Sectoral
| Health Technology | 23 |
| Commercial Services | 9 |
| Consumer Services | 7 |
| Finance | 5 |
| Health Services | 4 |
Operational
| Director/Board Member | 275 |
| Chairman | 92 |
| Corporate Officer/Principal | 74 |
| Chief Executive Officer | 55 |
| Independent Dir/Board Member | 52 |
Most connected contacts
- Stock Market
- Insiders
- Tomas Odergren
- Company connections
